HYTN Innovations Inc.

HYTN

CA40443L1040

Non-Alcoholic Beverages

Delayed Canadian Securities Exchange Other stock markets 09:41:32 2024-05-29 EDT			5-day change	1st Jan Change
0.36 ^CAD	+2.86%		+33.33%	+414.29%

03-26	HYTN Innovations Inc. announced that it has received CAD 0.74855 million in funding	CI
02-29	HYTN Innovations Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	CI

HYTN Innovations Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023

February 29, 2024 at 05:35 pm

HYTN Innovations Inc. reported earnings results for the first quarter ended December 31, 2023. For the first quarter, the company reported sales was CAD 0.197841 million compared to CAD 0.296858 million a year ago. Net loss was CAD 0.229524 million compared to CAD 0.672195 million a year ago.

Latest news about HYTN Innovations Inc.

HYTN Innovations Inc. announced that it has received CAD 0.74855 million in funding	03-25	CI
HYTN Innovations Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	02-29	CI
HYTN Innovations Inc. Announces Expansion of 100 MG Nano Shot Citrus to Western Canada	02-20	CI
HYTN Innovations Inc. announced that it expects to receive CAD 1 million in funding	02-08	CI
HYTN Innovations Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	01-28	CI
HYTN Innovations Inc. announced that it has received CAD 0.505 million in funding	23-10-25	CI
HYTN Innovations Inc. announced that it expects to receive CAD 1 million in funding	23-09-25	CI
HYTN Innovations Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	23-08-28	CI
HYTN Innovations Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	23-05-29	CI
Hytn Innovations Inc. Announces Board Resignations	23-04-12	CI
Hytn Innovations Inc. Submits an Amendment to Its Controlled Drugs and Substances Dealers License with Health Canada	23-03-02	CI
HYTN Innovations Inc. Expands its Controlled Drugs and Substances Dealers License to Include Mdma and Ketamine	23-03-02	CI
HYTN Innovations Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022	23-02-27	CI
HYTN Innovations Cultivates Psilocybin Mushrooms and Upgrades Equipment for API Development	23-02-23	CI
HYTN Innovations Inc. Auditor Raises 'Going Concern' Doubt	23-01-29	CI
HYTN Innovations Inc. Reports Earnings Results for the Full Year Ended September 30, 2022	23-01-29	CI
Hytn Innovations Inc. Announces That Its Wholly Owned Subsidiary, Hytn Cannabis Inc. Enters into Sales, Distribution and Marketing Agreement with Rose Lifescience Inc	22-10-24	CI
Hytn Opens Provincial and Territorial Markets for Tricanna Manufactured Pre-Rolled Cannabis Products	22-09-29	CI
HYTN Cannabis Inc Announces Launch of Rapid Onset Nano Gummies	22-08-29	CI
HYTN Secures Cannabis Cultivation License to Elevate the Quality of Its Cannabis Inputs	22-06-14	CI
HYTN Grows Exports with Cannabis Flower Sales to Australia	22-03-30	CI
HYTN Innovations Inc. Begins Accepting Orders Directly from Provinces and Territories	22-03-17	CI
HYTN Innovations Inc. Expands as Cannabis Products Launch in Australia	22-02-28	CI
HYTN Innovations Inc. Announces its Wholly Owned Subsidiary, HYTN Cannabis Inc. Receives Approval for the Sale of Cannabis to Provincially and Territorially Authorized Retailers	22-02-22	CI
HYTN Innovations Inc. Auditor Raises 'Going Concern' Doubt	22-02-17	CI

Chart HYTN Innovations Inc.

Duration

Period

More charts

Company Profile

HYTN Innovations Inc. is a Canada-based company that creates products containing psychoactive and psychotropic compounds, including cannabinoids derived from cannabis. The Company formulates, manufactures, markets, and sells cannabis goods. It is engaged in the development of the sparkling tetrahydrocannabinol and the cannabidiol beverage business. All its sparkling cannabis beverages contain 10 milligrams (mg) of THC and are made using its process, Elevation Technology. Its products include Rosewater Lemonade, Watermelon Mint, Lemongrass Ginger, and Blood Orange. Its Rosewater Lemonade is a sugar-free exploration of citrus accented with floral notes. Blood Orange is formulated to bring out the sweet flavors found in this seasonal citrus fruit. Its activities are focused on a single production and manufacturing facility, based in Kelowna, British Columbia. The Companyâs subsidiaries include HYTN Innovations Inc., HYTN Beverage Corp, HYTN Cannabis Inc., and 1306562 B.C. Ltd.

Sector

Non-Alcoholic Beverages

Calendar

2024-08-22 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Non-Alcoholic Beverages

	1st Jan change	Capi.
HYTN INNOVATIONS INC.	+414.29%	19.85M
THE COCA-COLA COMPANY	+3.89%	266B
KEURIG DR PEPPER INC.	+0.29%	45.7B
VARUN BEVERAGES LIMITED	+15.64%	22.96B
CELSIUS HOLDINGS, INC.	+45.63%	19.33B
ARCA CONTINENTAL, S.A.B. DE C.V.	-12.75%	16.4B
COCA-COLA HELLENIC	+18.79%	12.86B
SWIRE PACIFIC LIMITED	+4.16%	11.24B
SUNTORY BEVERAGE & FOOD LIMITED	+22.26%	11.21B
COCA-COLA CONSOLIDATED, INC.	+5.23%	9.26B